SF3566
Treatments that may harm fertility informed consent requirement provision
Legislative Session 94 (2025-2026)
AI Generated Summary
Purpose
- The bill would require health care providers to obtain informed, written consent before performing medical treatments that may harm a patient’s fertility. It aims to ensure patients are informed about potential fertility risks and have access to information and options related to fertility preservation and family building.
Definitions (key terms)
- Family building: How a person forms a family, including both biological and nonbiological steps.
- Fertility: The ability to conceive or carry biological children.
- Fertility specialist: A health care provider with expertise in reproductive health and fertility preservation.
- Health care provider: A licensed or registered health professional practicing within their licensed scope and state law.
- Medical treatment: Any prescription drug, procedure, therapy, or intervention that may impact fertility.
- Patient: The person receiving medical treatment.
Main Provisions
Informed consent requirement:
- A health care provider must discuss with the patient the potential harm a treatment could have on the patient’s fertility.
- The provider must give the patient an opportunity to consult with a fertility specialist about the treatment’s impact, fertility preservation options, and family building options.
- The patient must give prior written informed consent, affirming they were informed about the fertility risks, understood them, and authorize the treatment.
Prohibited conduct:
- Providers must not influence a patient’s decision by discouraging the patient from consulting a fertility specialist or exploring fertility preservation or family-building options.
Disciplinary action:
- A health care provider who violates the requirements could face disciplinary action from the relevant licensing board.
- A patient harmed by the violation may file a complaint with the appropriate licensing board.
Oversight and monitoring:
- The commissioner of health must establish procedures to monitor compliance with these requirements.
Significance and Potential Impact
- Establishes a formal, patient-centered process to consider fertility impacts before treatment.
- Requires proactive discussion and access to fertility-related information and services.
- Introduces accountability through licensing boards and state health oversight.
- May influence how health care providers counsel patients and obtain consent for treatments with fertility implications.
How this changes existing law
- Creates a new state requirement for informed consent specifically tied to treatments that may affect fertility.
- Adds defined terms related to fertility, preservation, and family building to guide practice.
- Shifts some responsibility for oversight and enforcement to licensing boards and the commissioner of health.
Relevant Terms - informed consent - fertility - fertility preservation - family building - fertility specialist - health care provider - medical treatment - patient - health-related licensing board - commissioner of health - disciplinary action - consult with a fertility specialist - monitoring compliance
Past committee meetings
You must be logged in to view 1 past legislative committee meetings.
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 17, 2026 | Senate | Action | Introduction and first reading | ||
| February 17, 2026 | Senate | Action | Referred to | Health and Human Services |
Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.